Institute Of Biomedical Research

(OTC) MRES

Current Price$0.00

Market Cap$2.58M

Since IPO (2005)-100%

5 Year-95%

1 Year-93%

1 Month-41%

Institute Of Biomedical Research Financials at a Glance

Market Cap

$2.58M

Revenue (TTM)

$27.71K

Net Income (TTM)

-$2.46M

EPS (TTM)

-$0.00

P/E Ratio

-1.04

Dividend

$0.00

Beta (Volatility)

0.66 (Low)

Dividend

$0.00

Beta (Volatility)

0.66 (Low)

Price

$0.00

Volume

651,000

Open

$0.00

Price

$0.00

Volume

651,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.66 (Low)

Price

$0.00

Volume

651,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

N/A

MRES News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Institute Of Biomedical Research

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

CEO

Peter Jeffrey Robinson

Website

www.mrescorp.com

Headquarters

Podgorica, 81000, ME

MRES Financials

Key Financial Metrics (TTM)

Gross Margin

-5.42%

Operating Margin

-1106.46%

Net Income Margin

-8882.84%

Return on Equity

-1825.86%

Return on Capital

N/A

Return on Assets

-5643.00%

Earnings Yield

-96.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.58M

Shares Outstanding

2.75B

Volume

651.00K

Avg. Volume

1.28M

Financials (TTM)

Gross Profit

-$1.50K

Operating Income

-$306.56K

EBITDA

-$306.56K

Operating Cash Flow

-$151.59K

Capital Expenditure

$0.00

Free Cash Flow

-$151.59K

Cash & ST Invst.

$13.01K

Total Debt

$0.00

Institute Of Biomedical Research Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$9.97K

-209.2%

Gross Margin

0.00%

N/A

Market Cap

$2.58M

N/A

Market Cap/Employee

$369.20K

N/A

Employees

N/A

Net Income

-$957.31K

-559.6%

EBITDA

-$76.62K

+74.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

$13.01K

+10.2%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-56.43%

N/A

Return on Invested Capital

61.79%

N/A

Free Cash Flow

-$5.18K

+94.7%

Operating Cash Flow

-$5.18K

+94.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HSITFHadasit Bio-Holdings Ltd

HSITFHadasit Bio-Holdings Ltd$0.12+0.00%

ISCNFIsracann Biosciences Inc.

ISCNFIsracann Biosciences Inc.$0.00+0.00%

CLYYFCelyad Oncology S.A.

CLYYFCelyad Oncology S.A.$0.25+0.00%

FNCHFinch Therapeutics Group, Inc.

FNCHFinch Therapeutics Group, Inc.$8.70+16.00%

RVXCFResverlogix Corp.

RVXCFResverlogix Corp.$0.07+10.71%

BBIXFBonus Biogroup Ltd.

BBIXFBonus Biogroup Ltd.$0.11+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

CLROClearOne

CLROClearOne$6.48+1.01%

ONDSOndas

ONDSOndas$7.41-0.06%

NOKNokia

NOKNokia$12.07-0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.95+0.05%

Questions About MRES

What is the current price of Institute Of Biomedical Research?

Institute Of Biomedical Research is trading at $0.00 per share.

What is the 52-week range for Institute Of Biomedical Research?

Over the past 52 weeks, Institute Of Biomedical Research has traded between $0.00 and $0.02.

How much debt does Institute Of Biomedical Research have?

As of the most recent reporting period, Institute Of Biomedical Research reported total debt of $0.00.

How much cash does Institute Of Biomedical Research have on hand?

Institute Of Biomedical Research reported $13.01K in cash and cash equivalents in its most recent financial results.

What is Institute Of Biomedical Research’s dividend yield?

Institute Of Biomedical Research does not currently have a dividend yield.

Institute Of Biomedical Research

Institute Of Biomedical Research Financials at a Glance

MRES News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Institute Of Biomedical Research

MRES Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Institute Of Biomedical Research Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MRES

What is the current price of Institute Of Biomedical Research?

What is the 52-week range for Institute Of Biomedical Research?

How much debt does Institute Of Biomedical Research have?

How much cash does Institute Of Biomedical Research have on hand?

What is Institute Of Biomedical Research’s dividend yield?

Premium Investing Services